Hormone Sensitive Prostate Cancer
1 competing product in clinical development for Hormone Sensitive Prostate Cancer.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Enzalutamide + Placebo (No longer applicable in Open Label study period) + Leuprolide Open Label | Astellas Pharma | Phase 3 | Active | 44 |